VisualSonics Announces Next Generation In Vivo Imaging Technology to Make Strides in Cancer Risk Reduction, Early Detection, Patient Care, and Survivorship (SONO)

VisualSonics a wholly-owned subsidiary of SonoSite Inc., SONO, is demonstrating the recently announced Vevo® LAZR Photoacoustics Imaging system at the American Association of Cancer Research's annual conference The launch of VisualSonics' Vevo LAZR photoacoustics imaging system enables pre-clinical researchers to visualize structural, molecular and functional attributes of tumors simultaneously “With photoacoustics, we can see at the molecular level what effect a drug is having on cancer cells - it provides unparalleled insights into how cancer sustains itself and it's only a matter time before we begin seeing practical application in humans.” -Stanislav Emelianov, Associate Professor and Associate Chair for Research, Department of Biomedical Engineering, University of Texas at Austin